Therapeutic monitoring of antiepileptic drugs for epilepsy

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Tomson, Torbjörn ^a   Dahl, M L ^b   Kimland, E ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Anticonvulsants *administration dosage; blood ; Carbamazepine administration dosage; blood ; Drug monitoring; Epilepsy blood; *drug therapy ; Phenobarbital administration dosage; blood

Indexed keywords

RETRACTED ARTICLE; REVIEW;

EID: 34548192303     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002216.pub2     Document Type: Review

References (8)

1. Jannuzzi 2000 {published data only} Jannuzzi G, Cian P, Fattore C, Gatti G, Bartoli A, Monaco F, et al.A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. Epilepsia 2000;41(2):222- 30.
2. Fröscher 1981 Fröscher W, Eichelbaum M, Gugler R, Hildenbrand G, Penin H. A prospective randomised trial on the effect of monitoring plasma anticonvulsant levels in epilepsy. Journal of Neurology 1981;224:193-201.
3. Buchtal 1960 Buchtal F, Svensmark O. Aspects of pharmacology of phenytoin (Dilantin) and phenobarbital relevant to their dosage in the treatment of epilepsy. Epilepsia 1960;1:373-84.
4. Chadwick 1987 Chadwick DW. Overuse of monitoring of blood concentrations of antiepileptic drugs. British Medical Journal 1987;294:723-4.
5. Kutt 1968 Kutt H, McDowell F. Management of epilepsy with diphenylhydantoin sodium. JAMA 1968;203:969-72.
6. Kutt 1974 Kutt H, Penry JK. Usefulness of blood levels of antiepileptic drugs. Archives of Neurology 1974;31:283-8.
7. Lund 1974 Lund L. Anticonvulsant effect of diphenylhydantoin relative to plasma levels. Archives of Neurology 1974;31(5):289- 94.
8. Tomson 2000 Tomson T, Johannessen SI. Therapeutic monitoring of the new antiepileptic drugs. European Journal of Clinical Pharmacology 2000;55:697-705.